Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea.

Martin DJ, Badwan K, Parker M, Mulhall JP.

J Urol. 2002 Dec;168(6):2483-5.

PMID:
12441945
2.

Intralesional verapamil for the treatment of Peyronie's disease: a review.

Levine LA, Estrada CR.

Int J Impot Res. 2002 Oct;14(5):324-8. Review.

3.

Critical analysis of surgery for Peyronie's disease.

Kendirci M, Hellstrom WJ.

Curr Opin Urol. 2004 Nov;14(6):381-8. Review.

PMID:
15626883
4.

Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.

Lacy GL 2nd, Adams DM, Hellstrom WJ.

Int J Impot Res. 2002 Oct;14(5):336-9. Review.

5.

Review of current nonsurgical management of Peyronie's disease.

Levine LA.

Int J Impot Res. 2003 Oct;15 Suppl 5:S113-20. Review.

PMID:
14551587
6.

Pharmacological Management of Peyronie's Disease.

Trost LW, Gur S, Hellstrom WJ.

Drugs. 2007;67(4):527-45. Review.

PMID:
17352513
7.

Transdermal and topical pharmacotherapy for male sexual dysfunction.

Ohebshalom M, Mulhall JP.

Expert Opin Drug Deliv. 2005 Jan;2(1):115-20. Review.

PMID:
16296739
8.

Medical management of Peyronie's disease.

Hellstrom WJ.

J Androl. 2009 Jul-Aug;30(4):397-405. doi: 10.2164/jandrol.108.006221. Epub 2008 Oct 30. Review.

9.

Surgical approaches for advanced Peyronie's disease patients.

Hellstrom WJ, Usta MF.

Int J Impot Res. 2003 Oct;15 Suppl 5:S121-4. Review.

PMID:
14551588
10.

[Penile tunica albuginea plication for the treatment of penile curvature secondary Peyronie's disease].

Cruceyra Betriu G, Duarte Ojeda JM, Martínez Silva V, Alvarez González E, Capitán Manjón C, Piedra Lara JD, Leiva Galvis O.

Arch Esp Urol. 2005 Jun;58(5):445-50. Review. Spanish.

PMID:
16078787
11.

The management of Peyronie's disease.

Ralph DJ, Minhas S.

BJU Int. 2004 Jan;93(2):208-15. Review.

PMID:
14690485
12.

Peyronie's disease: a review.

Briganti A, Salonia A, Deho F, Zanni G, Rokkas K, Rigatti P, Montorsi F.

Curr Opin Urol. 2003 Sep;13(5):417-22. Review.

PMID:
12917519
13.

Peyronie's disease: a critical appraisal of current diagnosis and treatment.

Smith JF, Walsh TJ, Lue TF.

Int J Impot Res. 2008 Sep-Oct;20(5):445-59. doi: 10.1038/ijir.2008.30. Epub 2008 Jul 24. Review.

PMID:
18650828
14.

History, epidemiology, and clinical presentation of Peyronie's disease.

Hellstrom WJ.

Int J Impot Res. 2003 Oct;15 Suppl 5:S91-2. Review.

PMID:
14551584
15.

Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease.

Bivalacqua TJ, Champion HC, Hellstrom WJ.

Int J Impot Res. 2002 Oct;14(5):345-52. Review.

16.

FastSize Medical Extender for the treatment of Peyronie's disease.

Levine LA, Newell MM.

Expert Rev Med Devices. 2008 May;5(3):305-10. doi: 10.1586/17434440.5.3.305. Review.

PMID:
18452379
17.

Peyronie's disease: evolving surgical management and the role of phosphodiesterase 5 inhibitors.

Al-Shaiji TF, Brock GB.

ScientificWorldJournal. 2009 Aug 31;9:822-45. doi: 10.1100/tsw.2009.101. Review.

18.

Pathophysiology of Peyronie's disease.

Moreland RB, Nehra A.

Int J Impot Res. 2002 Oct;14(5):406-10. Review.

19.

Peyronie's disease: advancements in recent surgical techniques.

Dean RC, Lue TF.

Curr Opin Urol. 2004 Nov;14(6):339-43. Review.

PMID:
15626876
20.

Surgical treatment of Peyronie's disease: a critical analysis.

Kadioglu A, Akman T, Sanli O, Gurkan L, Cakan M, Celtik M.

Eur Urol. 2006 Aug;50(2):235-48. Epub 2006 May 11. Review.

PMID:
16716495
Items per page

Supplemental Content

Write to the Help Desk